CAPR News

Pomerantz LLP Informs Shareholders of Class Action Against Capricor Therapeutics, Inc. – CAPR

Capricor Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Capricor Therapeutics, Inc. - CAPR

Pomerantz LLP Informs Shareholders of Class Action Against Capricor Therapeutics, Inc. – CAPR

CAPR FINAL DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - CAPR

CAPR 最終截止日期：全球投資者法律顧問 ROSEN 鼓勵蒙受損失超過 10 萬美元的 Capricor Therapeutics, Inc. 投資者在對 CAPR 提出證券集體訴訟的重要截止日期前聘請律師

Kaplan Fox Encourages Investors of Capricor Therapeutics, Inc. (CAPR) to Act Ahead of the Lead Plaintiff Deadline on September 28, 2026 Ready to Announce with Confidence?

CAPR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Capricor Therapeutics, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!

Kaplan Fox Notifies Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) of the Lead Plaintiff Deadline on September 28, 2026

CAPR DEADLINE NOTICE: Faruqi & Faruqi, LLP Reminds Capricor Investors of Securities Class Action Lawsuit Deadline on September 28, 2026

Pomerantz LLP Notifies Investors of Class Action Against Capricor Therapeutics, Inc. – CAPR